Donald Trump's recent medical report shows a BMI of 29.7, sparking discussions about his weight and health, despite claims of ...

The White House doctor recommended increased physical activity and weight loss.

Learn how to transition from injectable GLP-1s to oral options like Wegovy and Foundayo, with expert advice on dosing, side ...

Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs worldwide under brand names Ozempic ...

By Sriparna Roy May 26 (Reuters) - Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to $3.8 ...

Lilly will continue global launches despite MFN pricing uncertainty, Japan price cuts, and rising obesity-drug competition.

A new White House medical memo reveals Donald Trump has gained 14 pounds in a year, edging his BMI to the brink of obesity even as his doctor insists he is in 'excellent health'.

BofA Securities raised its price target on Eli Lilly to $1,251 from $1,133 and kept a Buy rating, saying the drugmaker remains well place ...

Eli Lilly (LLY) is back above $1 trillion, closing at its first record high since November, as Wall Street starts pricing in a drug many investors may not know yet: Reta. The stock is up more than 25% ...

The GLP-1 drug market has quickly become one of the fastest growing and most strategically important sectors in all of pharma. Used mainly to treat Type 2 diabetes and to help manage obesity through ...

Dr. Jeremy London operates on diseased hearts for a living. The four things he personally never eats might make you rethink your grocery list.

Novo Nordisk-linked pharmaceutical strength helped Denmark post a fourth straight quarter of economic expansion.